A phase-II clinical trial of 4?-epi-doxorubicin in advanced solid tumors
Cancer Chemotherapy and Pharmacology1984Vol. 12(3), pp. 179–82
Andrea Martoni, M Giovannini, Luciana Tomasi, Carlo Maurizio Camaggi, B Bellanova, N Monetti, Giovanni Rossini, M Tarquinii, Alfredo Martini, F Pannuti
Related Papers
- → Pentoxifylline as a modulator of anticancer drug doxorubicin. Part II: Reduction of doxorubicin DNA binding and alleviation of its biological effects(2016)29 cited
- Comparison of three approaches to doxorubicin therapy: free doxorubicin, liposomal doxorubicin, and beta-glucuronidase-activated prodrug (HMR 1826).(2000)
- → Effects of Different Doses of Doxorubicin on H9C2 Cells(2022)1 cited
- → The rat model in the comparative evaluation of anthracyclines cardiotoxicity.(1989)3 cited
- A comparison study of synthesizing methods of thiolated doxorubicin(2014)